An Update on Psychopharmacological Treatment of Autism Spectrum Disorder
Focus · 2024-04 · 22 (2) · 198-211
DOI: 10.1176/appi.focus.24022006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Focus, 2024-04. Verfasst von Ramkumar Aishworiya und 3 weiteren Autor:innen. Beteiligte Einrichtung: Medical Investigation of Neurodevelopmental Disorders (MIND) Institute, University of California Davis, 2825 50th Street, Sacramento, CA 95817, USA (…. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 150 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Investigation of Neurodevelopmental Disorders (MIND) Institute, University of California Davis, 2825 50th Street, Sacramento, CA 95817, USA (Aishworiya, Valica, Hagerman, Restrepo); Khoo Teck Puat-National Unive…
Zitieren
APA
Aishworiya, R., Valica, T., Hagerman, R., & Restrepo, B. (2024). An Update on Psychopharmacological Treatment of Autism Spectrum Disorder. Focus, 22(2), 198-211. https://doi.org/10.1176/appi.focus.24022006
Vancouver
Aishworiya R, Valica T, Hagerman R, Restrepo B. An Update on Psychopharmacological Treatment of Autism Spectrum Disorder. Focus. 2024;22(2):198-211. doi:10.1176/appi.focus.24022006
BibTeX
@article{Aishworiya2024,
author = {Aishworiya, Ramkumar and Valica, Tatiana and Hagerman, Randi and Restrepo, Bibiana},
title = {An Update on Psychopharmacological Treatment of Autism Spectrum Disorder},
journal = {Focus},
year = {2024},
volume = {22},
number = {2},
pages = {198--211},
doi = {10.1176/appi.focus.24022006}
}
EUVIMED